Clinical trial
Donor Dopamine and Initial Graft Function
NCT00115115 · Universitätsmedizin Mannheim, Other · Completed
Key facts
| NCT number | NCT00115115 |
|---|---|
| Title | Donor Dopamine and Initial Graft Function |
| Official title | Prospective Randomized Trial to Evaluate the Efficacy of Donor Preconditioning With Dopamine on Initial Graft Function After Kidney Transplantation |
| Lead sponsor | Universitätsmedizin Mannheim, Other |
| Collaborators | Eurotransplant International Foundation, Leiden, The Netherlands Regional Organ Procurement Organization (DSO), Baden-Wuerttemberg, Germany Regional Organ Procurement Organization (DSO), Bavaria… |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation, ESRD |
| Intervention type | Drug |
| Interventions | Dopamine infusion to brain dead organ donors |
| Enrollment | 487 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Jun 21, 2005 |
| Last update posted | Apr 23, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: